Published in Facts Views Vis Obgyn on January 01, 2009
Effects of Oncological Treatment During Pregnancy | NCT00330447
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med (2003) 11.93
Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature (1995) 5.91
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol (2008) 3.29
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol (1999) 2.97
Use of chemotherapy during human pregnancy. Lancet Oncol (2004) 2.59
Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.52
Association between method of delivery and maternal rehospitalization. JAMA (2000) 2.49
Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol (2004) 2.31
Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.30
Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol (2009) 2.14
Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer (2006) 2.04
Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann ICRP (2003) 1.91
Anesthesia in pregnant patients for nonobstetric surgery. J Clin Anesth (2006) 1.86
The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol (2004) 1.74
Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol (2008) 1.73
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70
The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A (1988) 1.69
Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys (1995) 1.65
Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol (2001) 1.56
Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer (2006) 1.54
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma (2001) 1.47
Breast cancer in pregnancy: a literature review. Arch Surg (2003) 1.41
Breast cancer and pregnancy. Breast (2007) 1.39
Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology (1986) 1.31
Pregnancy outcome following cancer chemotherapy. Am J Med (1980) 1.30
Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest (2007) 1.28
Fetal doses from radiological examinations. Br J Radiol (1999) 1.25
Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med (1992) 1.24
Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol (2006) 1.23
Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol (2005) 1.23
Radiotherapy during pregnancy: fact and fiction. Lancet Oncol (2005) 1.22
Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol (2007) 1.22
Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest (1999) 1.21
Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol (2003) 1.20
Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev (2008) 1.18
Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer (2005) 1.16
Carcinoma of the breast associated with pregnancy. Surg Gynecol Obstet (1985) 1.14
Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer (2001) 1.14
Antineoplastic agents and pregnancy. Semin Oncol (1989) 1.13
Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum Pathol (1987) 1.12
Breast cancer during pregnancy: a mini-review. Eur J Surg Oncol (2008) 1.12
Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol (2007) 1.11
In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol (1977) 1.11
Policies, guidelines, and recommendations for MR imaging safety and patient management. SMRI Safety Committee. J Magn Reson Imaging (1992) 1.09
Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol (1996) 1.09
Breast cancer in pregnancy. J Obstet Gynaecol (2006) 1.09
Threshold for radiation-related severe mental retardation in prenatally exposed A-bomb survivors: a re-analysis. Int J Radiat Biol (1996) 1.07
Imaging and Management of Breast Masses During Pregnancy and Lactation. Breast J (1999) 1.07
Fine needle aspiration of benign and malignant breast masses associated with pregnancy. Acta Cytol (1991) 1.06
Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol (2007) 1.04
Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol (2002) 1.04
Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim Biophys Acta (2006) 1.03
Treatment of breast tumors associated with pregnancy and lactation. Ann Surg (1962) 1.02
Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol (2007) 1.00
Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys (2003) 0.99
Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat (2007) 0.97
Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol (2003) 0.97
Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys (1998) 0.96
Pregnancy and breast cancer: a population-based study. Virchows Arch (2003) 0.96
Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer (2006) 0.96
The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev (2005) 0.94
Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet (1997) 0.93
Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med (2008) 0.93
Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol (2001) 0.92
Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. JAMA (1994) 0.92
Gynecologic oncology in pregnancy. Crit Rev Oncol Hematol (2008) 0.91
Measurement of the peripheral dose for the tangential breast treatment technique with Co-60 gamma radiation and high energy X-rays. Radiother Oncol (1997) 0.91
Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review. Int J Gynecol Cancer (2007) 0.91
Diagnostic nuclear medicine and risk for the fetus. Eur J Nucl Med (1998) 0.89
Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol (2006) 0.89
Radiation therapy in pregnancy: risk calculation and risk minimization. Semin Oncol (2000) 0.89
Children exposed to chemotherapy in utero. J Natl Cancer Inst Monogr (2005) 0.89
Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J (2008) 0.87
Scientific view of low-level radiation risks. Radiographics (1991) 0.87
Breast cancer during pregnancy. Oncology (Williston Park) (2001) 0.86
Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma. Arch Gynecol Obstet (2007) 0.86
The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J (2004) 0.86
Carcinoma of the breast and pregnancy; analysis of 920 cases collected from the literature and 22 new cases. Ann Surg (1954) 0.85
Pierre Robin sequence associated with first trimester fetal tamoxifen exposure. Am J Med Genet A (2008) 0.84
Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer (2004) 0.84
Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol (2005) 0.84
In utero exposure to chemotherapy: effect on cardiac and neurologic outcome. J Clin Oncol (2006) 0.83
Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta (2005) 0.83
Management of pregnancy-associated breast cancer. Breast (2006) 0.83
Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer (2006) 0.83
Fetal and neonatal effects of cytotoxic agents. Obstet Gynecol (1981) 0.82
Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. Eur J Obstet Gynecol Reprod Biol (2006) 0.82
Bone scanning in pregnant patients with breast carcinoma. Clin Nucl Med (1987) 0.82
Breast cancer and pregnancy. Ann Oncol (2005) 0.81
Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care (Engl) (2000) 0.81
Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol (2001) 0.81
Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res (2004) 0.81
Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer (2006) 0.80
Chemotherapy during pregnancy: what is really safe? Lancet Oncol (2004) 0.80
Magnetic resonance imaging of the chest, abdomen, and pelvis in the evaluation of pregnant patients with neoplasms. Am J Perinatol (2007) 0.80
Breast cancer and pregnancy: challenges of chemotherapy. Crit Rev Oncol Hematol (2008) 0.79
Breast cancer associated with pregnancy. Obstet Gynecol (1988) 0.79
Breast disease complicating pregnancy. Obstet Gynecol Clin North Am (1998) 0.78
Foetal radiation dose in radiotherapy for breast cancer. Australas Radiol (1992) 0.77